6 Responses

  1. Scott K. Johnson
    Scott K. Johnson June 14, 2006 at 6:53 am | | Reply


    That’s an approach I had not heard before. Very interesting.

    Thanks for the update!

  2. Eric Jensen
    Eric Jensen June 14, 2006 at 12:04 pm | | Reply

    Is the idea that the pores in the cage are large enough for insulin molecules and red blood cells to go in and out, but too small for white blood cells to get in and destroy the islet cells? They look too big for that (and I’m not even positive they’re different sizes, though I seem to recall reading an approach based on that idea).

  3. paul
    paul June 14, 2006 at 12:57 pm | | Reply

    no, this tech just provides an alternate site for implantation of islets; it allows vascularization of the subcutaneous space and a place for the islets to reside – it does not provide any immunoprotection.

  4. Sarah
    Sarah June 16, 2006 at 8:20 am | | Reply

    They actually are having clinical trials for a PEG at CHRISTUS Transplant Institute in San Antonio, TX. I think this is exciting, it is just unfortunate that the supply of islets is so small in comparison to the number of diabetics.

  5. Lyle
    Lyle June 16, 2006 at 10:17 am | | Reply

    This link will take you to the parent company doing the PEG encapsulated human islet allografts.

    They also have a plan for the short supply of islet cells

  6. Diabetes Daily
    Diabetes Daily June 17, 2006 at 3:37 pm | | Reply

    Insulin in a Pill and Other Great News

    Amy Tendrich of Diabetes Mine posted three inspiring stories this week. So you can smile, too, here they are: Insulin in a Pill? “Why don’t we have insulin in a pill? Because the stomach digests it before it gets into the bloodstream. Pharmaceutical co…

Leave a Reply